Production and purification of IL-29

Details for Australian Patent Application No. 2006299339 (hide)

Owner ZymoGenetics, Inc.

Inventors Zamost, Bruce L.; Lee, Geoffrey F.; Dedinsky, Robert M.

Agent Griffith Hack

Pub. Number AU-B-2006299339

PCT Pub. Number WO2007/041713

Priority 60/723,544 04.10.05 US

Filing date 4 October 2006

Wipo publication date 12 April 2007

Acceptance publication date 15 March 2012

International Classifications

C07K 14/54 (2006.01) Peptides having more than 20 amino acids

Event Publications

17 April 2008 PCT application entered the National Phase

  PCT publication WO2007/041713 Priority application(s): WO2007/041713

15 March 2012 Application Accepted

  Published as AU-B-2006299339

12 July 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006299345-Combination therapy using budesonide and antisense oligonucleotide targeted to IL4-receptor alpha

2006299338-Pyrazolopyrimidines as protein kinase inhibitors